This inventor holds 1 USPTO granted patent. Top assignee: Fdc Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Anand Mohan Chandavarkar
Introduction
Anand Mohan Chandavarkar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals through his innovative research and development efforts. His work focuses on the preparation of complex chemical compounds that have potential applications in medicine.
Latest Patents
Chandavarkar holds a patent for a process related to the preparation of 5,6-dihydro-4H-4(S)-ethylamino-6(S)-methylthieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide and its salt. This invention involves the resolution of (cis,trans)5,6-dihydro-4H-4-ethylamino-6-methylthieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide using dibenzoyl-L-tartaric acid monohydrate or di-p-toluoyl-L-tartaric acid monohydrate as a chiral resolving agent in the presence of methanol. The process yields a hemitartarate salt with a high degree of purity, achieving a chemical purity of over 99.5% and a de of greater than 99%. The final product can be converted into its pharmaceutically acceptable salts, preferably hydrochloride salt.
Career Highlights
Chandavarkar is currently associated with FDC Limited, a prominent company in the pharmaceutical sector. His work at FDC Limited has allowed him to contribute to the development of innovative pharmaceutical solutions that address various health challenges.
Collaborations
He has collaborated with notable colleagues such as Rajaram Uday Bapat and Anand Atul Bade, enhancing the research and development efforts within his team.
Conclusion
Anand Mohan Chandavarkar's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the industry positively, paving the way for future developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile